Boothbay Fund Management, LLC Standard Biotools Inc. Transaction History

Boothbay Fund Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.65 - $2.92 $426,478 - $754,738	-258,472 Reduced 77.93%	73,190 $129,000
Q1 2024 May 15, 2024	SELL	$1.87 - $2.78 $890,486 - $1.32 Million	-476,196 Reduced 58.95%	331,662 $898,000
Q4 2023 Feb 14, 2024	SELL	$1.59 - $2.73 $633,068 - $1.09 Million	-398,156 Reduced 33.01%	807,858 $1.79 Million
Q3 2023 Nov 14, 2023	SELL	$1.9 - $3.05 $2.08 Million - $3.34 Million	-1,096,264 Reduced 47.62%	1,206,014 $3.5 Million
Q3 2022 Nov 14, 2022	SELL	$1.1 - $2.06 $20,728 - $38,818	-18,844 Reduced 0.81%	2,302,278 $2.53 Million
Q2 2022 Aug 15, 2022	BUY	$1.6 - $3.99 $30,150 - $75,187	18,844 Added 0.82%	2,321,122 $3.71 Million
Q2 2021 Aug 16, 2021	BUY	$4.35 - $6.35 $7.99 Million - $11.7 Million	1,837,258 Added 395.09%	2,302,278 $14.2 Million
Q1 2021 May 17, 2021	BUY	$3.94 - $7.09 $1.83 Million - $3.3 Million	465,020 New	465,020 $2.1 Million

143

279M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $118M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.